Total Funding
69
55
Total FundingConvertible Note raised
Growth Score
-3 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
153337
Lophora develops new rapid-acting drugs for central nervous system diseases including treatment-resistant depression.
About the Company
Lophora develops new rapid-acting drugs for central nervous system diseases including treatment-resistant depression. Lophora has discovered and patented a new class of proprietary ligands with a similar pharmacological profile to psilocybin, which has demonstrated promising clinical results in the treatment of depression. Lophora's new drug
class can be used to treat other CNS disorders such as anxiety, PTSD, and substance abuse.
